中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
中国医药(600056) 利润表
单位:万元
报表日期2021-03-312020-12-312020-09-302020-06-302020-03-31
一、营业总收入857,190.523,931,175.353,026,727.481,880,922.61748,511.69
营业收入857,190.523,931,175.353,026,727.481,880,922.61748,511.69
二、营业总成本823,722.083,638,646.042,831,986.251,760,254.70707,458.86
营业成本736,520.933,251,222.792,539,585.131,568,922.79622,424.31
营业税金及附加2,596.8611,730.048,318.015,444.322,178.96
销售费用58,432.98248,456.23198,372.39128,324.0456,345.79
管理费用21,416.1093,121.2463,779.9041,453.2118,727.66
财务费用3,720.6525,735.9117,785.0313,109.886,246.14
研发费用1,034.568,379.834,145.803,000.451,535.99
资产减值损失----------
公允价值变动收益--65.5720.819.733.01
投资收益-654.803,751.435,388.012,132.18200.57
其中:对联营企业和合营企业的投资收益271.138,830.626,338.262,481.36427.00
汇兑收益----------
三、营业利润35,653.25193,918.66190,429.24119,659.8941,659.46
加:营业外收入323.41889.92717.16562.44239.85
减:营业外支出160.862,281.972,345.39612.19436.18
其中:非流动资产处置损失----------
四、利润总额35,815.80192,526.60188,801.01119,610.1441,463.14
减:所得税费用8,923.4853,918.5547,176.0931,401.1010,418.58
五、净利润26,892.32138,608.05141,624.9288,209.0431,044.56
归属于母公司所有者的净利润21,294.51131,064.57123,805.5777,748.2926,402.75
少数股东损益5,597.827,543.4817,819.3610,460.764,641.81
六、每股收益
基本每股收益(元/股)0.19931.22661.15870.72760.2471
稀释每股收益(元/股)0.19931.22661.15870.72760.2471
七、其他综合收益---346.72-16.39----
八、综合收益总额26,892.32138,261.33141,608.5388,209.0431,044.56
归属于母公司所有者的综合收益总额21,294.51130,730.58123,789.1777,748.2926,402.75
归属于少数股东的综合收益总额5,597.827,530.7517,819.3610,460.764,641.81
下载全部历史数据到excel中 返回页顶